Безопасен ли oligopeptide-123 rh-oligopeptide-1 при беременности?

Related ingredients

Frequently asked questions

Безопасен ли oligopeptide-123 rh-oligopeptide-1 при беременности?

No harmonised CLP reproductive classification (ECHA Annex VI) or CIR/SCCS safety opinion indicating reproductive hazard for oligopeptide‑1/rh‑oligopeptide‑1. Peer‑reviewed literature and product safety listings (CosIng, PubChem) describe it as a topical recombinant peptide (EGF) with no published developmental/teratogenic human data; dermal absorption of large peptides is generally limited, supporting negligible systemic exposure from cosmetic use (CosIng; PubMed).

Безопасен ли oligopeptide-123 rh-oligopeptide-1 при грудном вскармливании?

No evidence of reproductive or lactation toxicity or harmonised classification. Given lack of systemic toxicity data and expected minimal dermal absorption of a peptide of this size, systemic exposure in lactating people is expected to be negligible; therefore transfer into breastmilk is unlikely based on available sources (CosIng; PubMed).

Безопасен ли oligopeptide-123 rh-oligopeptide-1 для кожи малыша?

No intrinsic reproductive hazard identified. However, infant skin has a higher surface‑area‑to‑body‑weight and a less mature barrier which increases potential exposure from topical application; therefore exposure score increased by +1 relative to adults despite overall limited dermal absorption of peptides (general dermal pharmacokinetics literature; CosIng). No infant‑specific toxicity or developmental effects documented.

Как VeriMom оценивает oligopeptide-123 rh-oligopeptide-1?

VeriMom оценивает oligopeptide-123 rh-oligopeptide-1 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы oligopeptide-123 rh-oligopeptide-1 при беременности?

См. наш список безопасных альтернатив oligopeptide-123 rh-oligopeptide-1 с аналогичной функцией и классификацией без известных рисков.